Library
Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria.
26 April 2021. doid: 10.1016/j.jaip.2021.04.034
Buters TP, van der Velden WAC, Abdisalaam I, van Maaren MS, van Doorn MBA
View publicationAdvancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
